MELINTA THERAPEUTICS Trademark

Trademark Overview

On Friday, September 13, 2013, a trademark application was filed for MELINTA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MELINTA THERAPEUTICS trademark a serial number of 86063818. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, June 13, 2025. This trademark is owned by Rib-X Pharmaceuticals, Inc.. The MELINTA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery services; research and development of antibiotics
melinta therapeutics

General Information

Serial Number86063818
Word MarkMELINTA THERAPEUTICS
Filing DateFriday, September 13, 2013
Status800 - REGISTERED AND RENEWED
Status DateFriday, June 13, 2025
Registration Number4713360
Registration DateTuesday, March 31, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 26, 2014

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and Servicesdrug discovery services; research and development of antibiotics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 20, 2013
Primary Code042
First Use Anywhere DateMonday, October 7, 2013
First Use In Commerce DateMonday, October 7, 2013

Trademark Owner History

Party NameMELINTA SUBSIDIARY CORP.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameMELINTA THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNEW HAVEN, CT 06511
Party NameMELINTA THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNEW HAVEN, CT 06511
Party NameMELINTA THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressNEW HAVEN, CT 06511
Party NameRib-X Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06511

Trademark Events

Event DateEvent Description
Friday, September 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 27, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, December 26, 2013NON-FINAL ACTION WRITTEN
Thursday, December 26, 2013NON-FINAL ACTION E-MAILED
Thursday, December 26, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 27, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 28, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 28, 2014NOTICE OF REVIVAL - E-MAILED
Tuesday, September 17, 2013NEW APPLICATION ENTERED
Wednesday, December 25, 2013ASSIGNED TO EXAMINER
Friday, June 27, 2014TEAS PETITION TO REVIVE RECEIVED
Friday, June 27, 2014PETITION TO REVIVE-GRANTED
Friday, June 27, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 24, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 6, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 21, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 19, 2014USE AMENDMENT FILED
Friday, January 30, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 2, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, February 20, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 21, 2014ASSIGNED TO LIE
Tuesday, August 26, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 26, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 19, 2014TEAS STATEMENT OF USE RECEIVED
Saturday, February 21, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 30, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 29, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 29, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 13, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 30, 2021TEAS SECTION 8 & 15 RECEIVED
Friday, July 30, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, March 31, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 30, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, October 19, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sunday, March 31, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 7, 2025TEAS SECTION 8 & 9 RECEIVED
Friday, June 13, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 13, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, June 13, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, June 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 13, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, September 24, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

therapeutics melinta development antibiotics research services discovery drug